Research conducted in partnership with Ipsos introduces a new paradigm in leveraging psychographic insights to influence consumer financial behaviors. The financial services industry is experiencing a transformation, thanks to a recent study by Psympl, conducted in partnership with Ipsos. This research has introduced psychographic profiling into the realm of financial decision-making, offering a fresh perspective […]

Cmbio™, a global leader in multi-omics science and digital biology, announces a strategic partnership with Nimble Science, to deliver first in class high-quality, multi-omic data insights from the small intestine. Through this initiative, Nimble's SIMBA™ GI Health Data Platform will be combined with Cmbio's advanced expertise in multi-omics data integration to advance microbiome research and

IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its CRISPR-Tuberculosis (TB) Blood Test. This test is the first qualitative real-time polymerase chain reaction (PCR) assay to combine CRISPR technology, designed to detect Mycobacterium tuberculosis (Mtb) cell-free DNA in

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=124053&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Symbotic Inc. (NASDAQ:SYM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/symbotic-lawsuit-submission-form-2?prid=124052&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Zeta Global Holdings Corp. (NYSE:ZETA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zeta-global-holdings-corp-lawsuit-submission-form-2?prid=124050&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / If you suffered a loss on your Marqeta, Inc. (NASDAQ:MQ) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/marqeta-inc-lawsuit-submission-form?prid=124049&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

AUSTIN, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) — On the heels of President Trump's inauguration parade in which he doubled down on his promise to make service-industry workers' tips non-taxable, Requite Microfinance has launched Tap 'n Tip, a cutting-edge digital tipping platform designed to empower workers in the leisure, hospitality, and transportation industries by creating

Firmament, a leading provider of structured equity capital solutions to small- and medium-sized enterprises, announced today its strategic investment in BP Environmental Services (“BP” or the “Company”), one of North America's premier commercial waste and jobsite services companies. This transaction represents Firmament's ninth platform investment in the environmental services sector since its inception. https://mma.prnewswire.com/media/1721651/FIRMAMENT_ID_CENTERED_COLOR.jpg Founded

Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food security solutions, announced today the launch of Igenity® BCHF to improve overall bovine heart health standards. https://mma.prnewswire.com/media/2088599/Neogen_Corporation_Logo.jpg Bovine Congestive Heart Failure (BCHF) stands as a significant threat to cattle health and productivity, and this genomic test provides a new opportunity for improved selection for heart health.